SARS-CoV-2 variants- Evolution, spike protein, and vaccines

被引:35
作者
Chen, Kai-Wei K. [1 ]
Huang, Daniel Tsung-Ning [1 ,2 ]
Huang, Li -Min [3 ,4 ]
机构
[1] MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan
[2] MacKay Med Coll, Dept Med, Taipei, Taiwan
[3] Natl Taiwan Univ, Natl Taiwan Univ Childrens Hosp, Dept Pediat, Coll Med, Taipei, Taiwan
[4] Natl Taiwan Univ, Natl Taiwan Univ Childrens Hosp, Dept Pediat, Coll Med, 8 Zhongshan S Rd, Taipei, Taiwan
关键词
COVID-19; SARS-CoV-2; Spike mutations; Variant of concern; Vaccines; RECEPTOR-BINDING DOMAIN; CHADOX1; NCOV-19; COVID-19; MUTATIONS; BNT162B2; B.1.1.7; BOOST; P.1;
D O I
10.1016/j.bj.2022.04.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite the rising natural and vaccines mediated immunity, several countries have experienced a resurgence of the Coronavirus disease of 2019 (COVID-19) due to the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. From Alpha to Omicron, the variants of concern (VOC) have evolved several spike protein mutations that may have an impact on virus characteristics, such as transmissibility and antigenicity. In this review, we describe the evolution of SARS-CoV-2, summarize current knowledge of epidemiological and clinical features of the variants, and discuss the response strategies in terms of vaccines to reduce the burden of COVID-19.
引用
收藏
页码:573 / 579
页数:7
相关论文
共 92 条
[51]   Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant [J].
Madhi, S. A. ;
Baillie, V ;
Cutland, C. L. ;
Voysey, M. ;
Koen, A. L. ;
Fairlie, L. ;
Padayachee, S. D. ;
Dheda, K. ;
Barnabas, S. L. ;
Bhorat, Q. E. ;
Briner, C. ;
Kwatra, G. ;
Ahmed, K. ;
Aley, P. ;
Bhikha, S. ;
Bhiman, J. N. ;
Bhorat, A' E. ;
du Plessis, J. ;
Esmail, A. ;
Groenewald, M. ;
Horne, E. ;
Hwa, S-H ;
Jose, A. ;
Lambe, T. ;
Laubscher, M. ;
Malahleha, M. ;
Masenya, M. ;
Masilela, M. ;
McKenzie, S. ;
Molapo, K. ;
Moultrie, A. ;
Oelofse, S. ;
Patel, F. ;
Pillay, S. ;
Rhead, S. ;
Rodel, H. ;
Rossouw, L. ;
Taoushanis, C. ;
Tegally, H. ;
Thombrayil, A. ;
van Eck, S. ;
Wibmer, C. K. ;
Durham, N. M. ;
Kelly, E. J. ;
Villafana, T. L. ;
Gilbert, S. ;
Pollard, A. J. ;
de Oliveira, T. ;
Moore, P. L. ;
Sigal, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (20) :1885-1898
[52]   Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape [J].
McCarthy, Kevin R. ;
Rennick, Linda J. ;
Nambulli, Sham ;
Robinson-McCarthy, Lindsey R. ;
Bain, William G. ;
Haidar, Ghady ;
Duprex, W. Paul .
SCIENCE, 2021, 371 (6534) :1139-+
[53]   Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 [J].
Meng, Bo ;
Kemp, Steven A. ;
Papa, Guido ;
Datir, Rawlings ;
Ferreira, Isabella A. T. M. ;
Marelli, Sara ;
Harvey, William T. ;
Lytras, Spyros ;
Mohamed, Ahmed ;
Gallo, Giulia ;
Thakur, Nazia ;
Collier, Dami A. ;
Mlcochova, Petra ;
Duncan, Lidia M. ;
Carabelli, Alessandro M. ;
Kenyon, Julia C. ;
Lever, Andrew M. ;
De Marco, Anna ;
Saliba, Christian ;
Culap, Katja ;
Cameroni, Elisabetta ;
Matheson, Nicholas J. ;
Piccoli, Luca ;
Corti, Davide ;
James, Leo C. ;
Robertson, David L. ;
Bailey, Dalan ;
Gupta, Ravindra K. .
CELL REPORTS, 2021, 35 (13)
[54]   Discovery of an RNA virus 3′→5′ exoribonuclease that is critically involved in coronavirus RNA synthesis [J].
Minskaia, E ;
Hertzig, T ;
Gorbalenya, AE ;
Campanacci, V ;
Cambillau, C ;
Canard, B ;
Ziebuhr, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (13) :5108-5113
[55]  
Mohammed A., 2024, bioRxiv, DOI DOI 10.1101/2022
[56]  
Munro APS, 2021, LANCET, V398, P2258, DOI 10.1016/S0140-6736(21)02717-3
[57]  
Mykytyn AZ, 2022, bioRxiv, DOI DOI 10.1101/2022.02.23.481644
[58]  
National Institute for Communicable Diseases, 2021, TRACK SARS COV 2 VAR
[59]  
Outbreakinfo, 2021, VAR REP
[60]   Phylogenetic analysis of SARS-CoV-2 in the first few months since its emergence [J].
Pereson, Matias J. ;
Mojsiejczuk, Laura ;
Martinez, Alfredo P. ;
Flichman, Diego M. ;
Garcia, Gabriel H. ;
Di Lello, Federico A. .
JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) :1722-1731